News Releases

Nov 05, 2026

Climb Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates

Nov 04, 2026

Climb Bio to Present New Data for Budoprutug in Immune Thrombocytopenia at the 68th American Society of Hematology Annual Meeting and Exposition

Nov 02, 2026

Climb Bio to Present at Guggenheim 3rd Annual Healthcare Innovation Conference

Oct 24, 2026

Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026

Oct 23, 2026

Climb Bio and Mabworks Announce CLYM116/MIL116 Data Demonstrating Deep, Durable APRIL Suppression and ~70% Gd-IgA1 Reduction at ASN Kidney Week 2026

Oct 02, 2026

Climb Bio to Present New Data at American Society of Nephrology (ASN) Kidney Week 2026 for CLYM116 and Budoprutug